What are the medications used to treat seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Comprehensive Guide to Antiseizure Medications for Step 1 Preparation

Benzodiazepines are the first-line treatment for active seizures, followed by phenytoin/fosphenytoin, valproate, or levetiracetam as second-line agents based on the most recent guidelines. 1, 2

Classification of Antiseizure Medications by Mechanism of Action

Sodium Channel Blockers

  • Phenytoin/Fosphenytoin: First-generation sodium channel blocker used for focal seizures and generalized tonic-clonic seizures; requires monitoring for hypotension and cardiac arrhythmias during IV administration 1
  • Carbamazepine: First-generation agent effective for focal seizures; induces hepatic enzymes and has multiple drug interactions 3
  • Oxcarbazepine: Second-generation carbamazepine analog with fewer drug interactions; first-line for focal epilepsy 4, 5
  • Lamotrigine: Broad-spectrum agent effective for both focal and generalized seizures; first-line for focal epilepsy but requires slow titration 4, 5
  • Lacosamide: Newer agent that enhances slow inactivation of sodium channels; effective as monotherapy for focal seizures 5
  • Eslicarbazepine: Third-generation agent related to carbamazepine with improved tolerability profile 5

GABA Enhancers

  • Benzodiazepines (diazepam, lorazepam, midazolam): First-line for acute seizures and status epilepticus; act on GABA-A receptors 1, 2
  • Phenobarbital: Barbiturate that enhances GABA inhibition; used for refractory status epilepticus but has significant sedative effects 1, 2
  • Vigabatrin: Irreversibly inhibits GABA transaminase; used for infantile spasms and refractory focal seizures 5
  • Tiagabine: Inhibits GABA reuptake; adjunctive therapy for focal seizures 5

Glutamate Antagonists

  • Perampanel: AMPA receptor antagonist; adjunctive therapy for focal and generalized tonic-clonic seizures 5
  • Felbamate: NMDA receptor antagonist; reserved for refractory epilepsy due to risk of aplastic anemia and liver failure 5

Multiple Mechanisms

  • Valproate: Broad-spectrum agent effective for most seizure types; first-line for generalized epilepsy but has teratogenic potential 1, 2
  • Topiramate: Multiple mechanisms including sodium channel blockade and GABA enhancement; effective for focal and generalized seizures 6, 5
  • Zonisamide: Blocks sodium channels and T-type calcium channels; broad-spectrum agent 5

Synaptic Vesicle Protein 2A (SV2A) Binders

  • Levetiracetam: Binds to SV2A protein; broad-spectrum with minimal drug interactions; first-line option for both focal and generalized seizures 1, 2, 4
  • Brivaracetam: Higher affinity for SV2A than levetiracetam; fewer behavioral side effects 5

Memorization Strategies

Group by Mechanism of Action

  • Create a mnemonic for sodium channel blockers: "POLE-CL" (Phenytoin, Oxcarbazepine, Lamotrigine, Eslicarbazepine, Carbamazepine, Lacosamide) 3, 4, 5
  • GABA enhancers: "BPT-VT" (Benzodiazepines, Phenobarbital, Tiagabine, Vigabatrin, Topiramate) 1, 2, 6

Group by Clinical Use

  • Status epilepticus treatment ladder: Benzodiazepines → Phenytoin/Fosphenytoin/Valproate/Levetiracetam → Phenobarbital/Propofol 1, 2
  • First-line for focal epilepsy: "LOL" (Lamotrigine, Oxcarbazepine, Levetiracetam) 4, 5
  • First-line for generalized epilepsy: "VLT" (Valproate, Lamotrigine, Topiramate) 7, 4

Group by Side Effects

  • Enzyme inducers: "CPP" (Carbamazepine, Phenytoin, Phenobarbital) - remember these affect contraceptives and other medications 3
  • Cognitive impairment: "TPZ" (Topiramate, Phenobarbital, Zonisamide) 6, 5
  • Weight gain: "VCP" (Valproate, Carbamazepine, Pregabalin) 5
  • Weight loss: "TZ" (Topiramate, Zonisamide) 6, 5

Treatment Algorithms

Status Epilepticus Management

  1. First-line: Benzodiazepines (lorazepam IV, midazolam IM, or diazepam IV/rectal) 1, 2
  2. Second-line (if seizures persist after benzodiazepines):
    • Phenytoin/Fosphenytoin: 20 mg/kg IV at max rate of 50 mg/min 1, 2
    • Valproate: 20-30 mg/kg IV over 5-20 minutes (less hypotension than phenytoin) 1, 2
    • Levetiracetam: 30 mg/kg IV over 5 minutes 1, 2
  3. Refractory status epilepticus:
    • Midazolam: IV loading dose 0.15-0.20 mg/kg, followed by continuous infusion 2
    • Propofol: 2 mg/kg bolus, followed by 3-7 mg/kg/hour infusion 2
    • Pentobarbital: 13 mg/kg bolus, 2-3 mg/kg/hour infusion 2

Focal Epilepsy Treatment

  1. First-line monotherapy: Lamotrigine, Oxcarbazepine, or Levetiracetam 4, 5
  2. Alternative monotherapy: Carbamazepine, Topiramate, Zonisamide, or Lacosamide 4, 5
  3. Adjunctive therapy (if monotherapy fails): Add a second agent with a different mechanism of action 8

Generalized Epilepsy Treatment

  1. First-line: Valproate (avoid in women of childbearing potential), Lamotrigine, or Levetiracetam 7, 4
  2. Alternative options: Topiramate, Zonisamide, or Perampanel 5

Key Clinical Pearls

  • Approximately 60-70% of patients with epilepsy achieve seizure freedom with appropriate antiseizure medication 7, 4
  • Most patients are controlled on a single antiseizure medication; only a small proportion requires combination therapy 8
  • When seizures are difficult to control, always reassess the diagnosis of epilepsy and medication adherence 8
  • Antiseizure medications with enzyme-inducing properties (carbamazepine, phenytoin, phenobarbital) can worsen comorbid conditions and interact with many medications 3, 4
  • Prophylactic antiseizure medications are not recommended for patients with brain metastases who have not had seizures 1
  • For patients with epilepsy who develop status epilepticus, loading doses of their regular medications can be administered with minimal toxicity 9

By organizing antiseizure medications by mechanism, clinical use, and side effects, you'll be well-prepared for Step 1 questions on this topic.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Status Epilepticus Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Update on Antiseizure Medications 2025.

Continuum (Minneapolis, Minn.), 2025

Research

Epilepsy.

Disease-a-month : DM, 2003

Research

Treatment of acute and remote symptomatic seizures.

Current treatment options in neurology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.